Skip to main content

Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC).

Publication ,  Journal Article
Dorth, JA; Willett, C; Czito, BG
Published in: J Clin Oncol
February 2012

88 Background: Patterns of local-regional failure (LRF) after neoadjuvant chemoradiotherapy (CRT) and surgery for locally-advanced EC are poorly defined. METHODS: This study reviewed pts treated with CRT followed by surgery for M0 esophageal cancer from 1995-2009. Staging and regional nodes (supraclavicular (SCV) through celiac) were defined based on AJCC 7(th) edition. Patterns of first failure were analyzed. LRF included: 1) initially involved nodal failure (INF), 2) initially uninvolved (subclinical) nodal failure (SNF), and/or 3) anastomotic. Abdominal para-aortic failure (PAF) at or below the superior mesenteric artery was scored separately. Isolated SNF or PAF was defined as no other local or distant failure. Actuarial local-regional control (LRC), event-free survival (EFS), and overall survival (OS) were estimated by the Kaplan-Meier method. RESULTS: 156 patients were identified with a median age of 60 years. Primary location was upper in 1%, middle 17%, lower 32% and gastroesophageal junction (GEJ) 50% (Adeno: 79%; SCC: 21%). Staging included EUS (73%), CT (46%), and/or PET/CT (54%). 40% had stage II and 60% stage III disease. Concurrent CRT was primarily cisplatin/taxane and/or 5-FU-based. Primary RT fields (median dose: 45Gy) encompassed the tumor with an approximate 5 cm proximal and distal margin and included standard regional nodes. Boost fields (median total dose: 50.4Gy) encompassed gross disease with a 2 cm margin. Surgical technique was transhiatial (28%), Ivor-Lewis (47%), or tri-incisional (25%) with a median of 8 nodes dissected. Median f/u was 1.3 years. 2-yr LRC, EFS, and OS were 83%, 36%, and 49%. 2-yr SNF was 15% (n=14); anastomotic failure was 7% (n=7). SNFs were SCV (n=5), mediastinal (n=12), and/or celiac (n=3). 95% of SNFs were outside or near the margin of the primary RT fields. 2-yr isolated SNF was 3% (n=3), PAF was 11% (n=9), and isolated PAF 6% (n=5). CONCLUSIONS: SNF is the most common type of LRF after tri-modality therapy for locally-advanced EC. A limited subset of patients experience isolated SNF or PAF as first disease recurrence. The potential benefit of targeting additional SN or PA regions with RT is small and likely eclipsed by high rates of distant failure.

Duke Scholars

Published In

J Clin Oncol

EISSN

1527-7755

Publication Date

February 2012

Volume

30

Issue

4_suppl

Start / End Page

88

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dorth, J. A., Willett, C., & Czito, B. G. (2012). Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC). J Clin Oncol, 30(4_suppl), 88.
Dorth, J. A., C. Willett, and B. G. Czito. “Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC).J Clin Oncol 30, no. 4_suppl (February 2012): 88.
Dorth JA, Willett C, Czito BG. Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC). J Clin Oncol. 2012 Feb;30(4_suppl):88.
Dorth, J. A., et al. “Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC).J Clin Oncol, vol. 30, no. 4_suppl, Feb. 2012, p. 88.
Dorth JA, Willett C, Czito BG. Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC). J Clin Oncol. 2012 Feb;30(4_suppl):88.

Published In

J Clin Oncol

EISSN

1527-7755

Publication Date

February 2012

Volume

30

Issue

4_suppl

Start / End Page

88

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences